As we observed only minor or no effect of RAP1 on CP induction of DNA damage in NSCLC cells (Supplementary Figure S6), we infer that RAP1 mediates CP-resistance through reducing cytotoxic response to the DNA damage induced by CP. The gene discussed is TERF2IP; the disease is non-small cell lung carcinoma.